Company

J&J Reports Q4 and Full-Year 2023 Results with Strong MedTech and Pharmaceutical Growth

CompanyMedical Device

Establishment Labs Launches Motiva Breast Implants in China

Company

Jiuzhou Pharmaceutical Expands with $42 Million Investment in Japanese CRO Services

CompanyMedical Device

Zylox-Tonbridge Medical Technology Secures NMPA Nod for Innovative Iliac Vein Stent System

CompanyDrug

Eisai’s Uric Acid Excretion Drug Urece Accepted for Review in China

CompanyDrug

Hansoh Pharmaceutical Gets NMPA Approval for Type 2 Diabetes and Obesity Drug Trial

CompanyMedical Device

Jiangsu Wuzhong Pharmaceutical’s Aesthetics Subsidiary Wins Approval for Facial Filler in China

CompanyMedical Device

Lepu Medical Technology Gains NMPA Approval for Innovative Coronary Device

Company

LifeShield Medical Launches China HQ and Advanced Heart System Factory in Suzhou

CompanyDeals

Tencent’s WeDoctor Teams Up with Guiyang for Digital Health Community Initiative

CompanyDeals

Sandoz Strikes Deal to Acquire Coherus Biosimilar for Ophthalmic Treatment

CompanyDrug

HuidaGene Therapeutics’ CRISPR Therapy Earns Orphan Drug Status for Duchenne Muscular Dystrophy